Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Alamar Biosciences, Inc. (ALMR)

$25.88 -0.04% NASDAQ: ALMR · 15-min delayed
  • FREMONT, California
  • Public · NASDAQ: ALMR
$1.8BMarket cap
$26.0MRevenue · FY2026
-$21.3MNet income
ALMRNASDAQ
2026IPO

About Alamar Biosciences, Inc.

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2026
$26.0M
Net income
-$21.3M
Total assets
$186.5M
Market cap
$1.8B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ALMR
$25.88 -0.04%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$19.09 $28.42

52-week range

Market cap
$1.8B
Shares outstanding
55.0M
Open
Day range
Prev close
Volume
IPO date
Apr 17, 2026

Alamar Biosciences, Inc. (ALMR) Stock Price

  • Reported a net loss of $21.3M in FY2026.
  • Trading 9% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Alamar Biosciences, Inc..

Write a review
Newsroom

News about Alamar Biosciences, Inc.

News & sentiment via Polygon.io

FAQ

Alamar Biosciences, Inc.: frequently asked questions

Is Alamar Biosciences, Inc. an American company?

Alamar Biosciences, Inc. is a US-based company headquartered in Fremont, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Alamar Biosciences, Inc. headquartered?

Alamar Biosciences, Inc. is headquartered in Fremont, California, United States.

Is Alamar Biosciences, Inc. publicly traded?

Yes — Alamar Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol ALMR on the NASDAQ.

What does Alamar Biosciences, Inc. do?

Alamar Biosciences, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →